SPOT-MAS 10
Blood-based multi-cancer screening test using cfDNA methylation and fragmentomic signals with machine learning.
- Developer
- Gene Solutions
- Intended use
- Multi Cancer Screening
- Cancer scope
- Not reported
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA methylation, Fragmentomics
- Current version
- SPOT-MAS 10 current configuration (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.